Effect of Tetracyclines on the Dynamics of Formation and Destructuration of β2-Microglobulin Amyloid Fibrils

• DOI: 10.1074/jbc.m110.178376
• Publication Date: 2010-11-11T01:18:02Z
• Authors: Sofia Giorgetti; Sara Raimondi; Katiuscia Pagano; Annalisa Relini; Monica Bucciantini; Alessandra Corazza; Federico Fogolari; Luca Codutti; Mario Salmona; Palma Mangione; Lino Colombo; Ada De Luigi; Riccardo Porcari; Alessandra Gliozzi; Massimo Stefani; Gennaro Esposito; Vittorio Bellotti; Monica Stoppini
• Keywords: 570; Amyloid; 0303 health sciences; Drug Evaluation, Preclinical; 610; Amyloidosis; Trifluoroethanol; tetracyclines; Anti-Bacterial Agents; 3. Good health; beta2-microglobulin; aggregazione amiloide, fibrillogenesi, inibitori dell'aggregazione, fluorescenza, microscopia a forza atomica, risonanza magnetica nucleare; 03 medical and health sciences; Cell Line, Tumor; Doxycycline; amyloid fibril; Humans; beta 2-Microglobulin; Nuclear Magnetic Resonance, Biomolecular

The discovery of methods suitable for the conversion in vitro of native proteins into amyloid fibrils has shed light on the molecular basis of amyloidosis and has provided fundamental tools for drug discovery. We have studied the capacity of a small library of tetracycline analogues to modulate the formation or destructuration of β2-microglobulin fibrils. The inhibition of fibrillogenesis of the wild type protein was first established in the presence of 20% trifluoroethanol and confirmed under a more physiologic environment including heparin and collagen. The latter conditions were also used to study the highly amyloidogenic variant, P32G. The NMR analysis showed that doxycycline inhibits β2-microglobulin self-association and stabilizes the native-like species through fast exchange interactions involving specific regions of the protein. Cell viability assays demonstrated that the drug abolishes the natural cytotoxic activity of soluble β2-microglobulin, further strengthening a possible in vivo therapeutic exploitation of this drug. Doxycycline can disassemble preformed fibrils, but the IC(50) is 5-fold higher than that necessary for the inhibition of fibrillogenesis. Fibril destructuration is a dynamic and time-dependent process characterized by the early formation of cytotoxic protein aggregates that, in a few hours, convert into non-toxic insoluble material. The efficacy of doxycycline as a drug against dialysis-related amyloidosis would benefit from the ability of the drug to accumulate just in the skeletal system where amyloid is formed. In these tissues, the doxycycline concentration reaches values several folds higher than those resulting in inhibition of amyloidogenesis and amyloid destructuration in vitro.